Meyka AI API is live for developers.Start building.
Advertisement
LumiraDx Limited

LumiraDx Limited (LMDXW) Stock Overview

Explore LumiraDx Limited’s financial performance, market position, analyst ratings, and future outlook.

LMDXW●NASDAQ
HealthcareMedical - Diagnostics & Research
$0.004
$0.00(0.00%)
U.S. Market opens in 64h 34m
Advertisement

LumiraDx Limited (LMDXW)

Meyka AI Score

Z

Key Financials

Market Cap5.1M
P/E Ratio-0.01
EPS (TTM)$-2.93
ROE-15.58%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

LMDXW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of LumiraDx Limited (LMDXW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.01 and a market capitalization of 5.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
-99.53%
5-Year Change
-99.63%
All-Time (Max) Change
-99.63%

Contact Information

http://www.lumiradx.com
44 11 7284 2535
3 More London Riverside, London, NaN, SE1 2AQ

Company Facts

12,100 Employees
IPO DateSep 29, 2021
CountryGB

Frequently Asked Questions